Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 StudySilvia Novello, Luis Paz‐Ares, David Vicente et al.|Journal of Clinical Oncology|2023Cited by 541
Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small<scp>‐</scp>cell lung cancer in KEYNOTE‐407Shunichi Sugawara, Terufumi Kato, Kentaro Tanaka et al.|Cancer Science|2023Cited by 16